Skip to main content
. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2

Analysis 21.27.

Analysis 21.27

Comparison 21 Resolution of encephalopathy ‐ absolute risk difference (ARD), Outcome 27 ITT ‐ Supplement trials ‐ best‐case scenario ‐ no changes made because all patients reported.